UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

CCL2/CCR2 signaling in cancer pathogenesis

Cell communication and signaling, 2020-05, Vol.18 (1), p.82-82, Article 82

2020

Link zum Volltext

Verfügbarkeit prüfen

Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells

PloS one, 2013-12, Vol.8 (12), p.e83971-e83971

2013

Link zum Volltext

Verfügbarkeit prüfen

MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis

Breast cancer research and treatment, 2018-08, Vol.170 (3), p.477-486

2018

Link zum Volltext

Verfügbarkeit prüfen

The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients

International Journal of Molecular Sciences, 2013-09, Vol.14 (9), p.18925-18958

2013

Link zum Volltext

Verfügbarkeit prüfen

AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer

Breast cancer research : BCR, 2019-02, Vol.21 (1), p.29-29, Article 29

2019

Link zum Volltext

Verfügbarkeit prüfen

Epithelial-Mesenchymal Transition and Breast Cancer

Journal of clinical medicine, 2016-01, Vol.5 (2), p.13

2016

Link zum Volltext

Verfügbarkeit prüfen

Tumor-Derived Exosomes in Tumor-Induced Immune Suppression

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1461

2022

Link zum Volltext

Verfügbarkeit prüfen

PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers

Journal of clinical medicine, 2019-03, Vol.8 (4), p.435

2019

Link zum Volltext

Verfügbarkeit prüfen

Sensitization to docetaxel in prostate cancer cells by green tea and quercetin

The Journal of nutritional biochemistry, 2015-04, Vol.26 (4), p.408-415

2015

Link zum Volltext

Verfügbarkeit prüfen

STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits

International journal of oncology, 2014-02, Vol.44 (2), p.403-411

2014

Link zum Volltext

Verfügbarkeit prüfen

Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status

Journal of clinical medicine, 2020-03, Vol.9 (4), p.940

2020

Link zum Volltext

Verfügbarkeit prüfen

Triple negative breast tumors in African-American and Hispanic/Latina women are high in CD44+, low in CD24+, and have loss of PTEN

PloS one, 2013-10, Vol.8 (10), p.e78259-e78259

2013

Link zum Volltext

Verfügbarkeit prüfen

Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy

Journal of experimental & clinical cancer research, 2016-05, Vol.35 (73), p.73, Article 73

2016

Link zum Volltext

Verfügbarkeit prüfen

Lactate, a Neglected Factor for Diabetes and Cancer Interaction

Mediators of inflammation, 2016-01, Vol.2016, p.6456018-12

2016

Link zum Volltext

Verfügbarkeit prüfen

Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12 , 1918

Cancers, 2024-03, Vol.16 (5), p.1026

2024

Link zum Volltext

Verfügbarkeit prüfen

IGF-1 regulates Cyr61 induced breast cancer cell proliferation and invasion

PloS one, 2014-07, Vol.9 (7), p.e103534-e103534

2014

Link zum Volltext

Verfügbarkeit prüfen

Correction: Dutta et al. Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer. Cancers 2020, 12 , 1317

Cancers, 2023-12, Vol.16 (1), p.7

2023

Link zum Volltext

Verfügbarkeit prüfen

Proinflammatory Cytokines IL-6 and TNF-α Increased Telomerase Activity through NF-κB/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells

Mediators of inflammation, 2017-01, Vol.2017, p.5958429-11

2017

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women

PloS one, 2013-03, Vol.8 (3), p.e57967-e57967

2013

Link zum Volltext

Verfügbarkeit prüfen

Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers

Cancers, 2020-07, Vol.12 (7), p.1918

2020

Link zum Volltext

Verfügbarkeit prüfen

Advancing Cancer Research: Insights and Innovations in Pathogenesis and Targeted Therapies

Journal of personalized medicine, 2023-02, Vol.13 (3), p.375

2023

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer

Cancers, 2020-05, Vol.12 (5), p.1317

2020

Link zum Volltext

Verfügbarkeit prüfen

Celecoxib in breast cancer prevention and therapy

Cancer management and research, 2018-01, Vol.10, p.4653-4667

2018

Link zum Volltext

Verfügbarkeit prüfen

Roles of Protein Disulfide Isomerase in Breast Cancer

Cancers, 2022-01, Vol.14 (3), p.745

2022

Link zum Volltext

Verfügbarkeit prüfen

Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor

Scientific reports, 2020-01, Vol.10 (1), p.1403, Article 1403

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(122)
Mit Volltextzugriff
(121)

Publikationsform

Artikel
(134)
Buchkapitel
(1)

Sprache

Englisch
(135)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

CCL2/CCR2 signaling in cancer pathogenesis

Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells

MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis

The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients

AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer

Epithelial-Mesenchymal Transition and Breast Cancer

Tumor-Derived Exosomes in Tumor-Induced Immune Suppression

PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers

Sensitization to docetaxel in prostate cancer cells by green tea and quercetin

STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits

Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status

Triple negative breast tumors in African-American and Hispanic/Latina women are high in CD44+, low in CD24+, and have loss of PTEN

Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy

Lactate, a Neglected Factor for Diabetes and Cancer Interaction

Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12 , 1918

IGF-1 regulates Cyr61 induced breast cancer cell proliferation and invasion

Correction: Dutta et al. Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer. Cancers 2020, 12 , 1317

Proinflammatory Cytokines IL-6 and TNF-α Increased Telomerase Activity through NF-κB/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells

Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women

Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers

Advancing Cancer Research: Insights and Innovations in Pathogenesis and Targeted Therapies

Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer

Celecoxib in breast cancer prevention and therapy

Roles of Protein Disulfide Isomerase in Breast Cancer

Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor

Suchergebnisse filtern